Abstract | BACKGROUND & AIMS: METHODS: Consecutive cirrhotic patients who recovered from HE were randomized to receive lactulose (HE-L group) or placebo (HE-NL group). All patients were assessed by psychometry (number connection test [NCT-A and B], figure connection test if illiterate [FCT-A and B], digit symbol test [DST], and object assembly test [OAT]), critical flicker frequency test, and blood ammonia at inclusion. Primary end point was development of overt HE. RESULTS: Of 300 patients with HE who recovered, 140 (46.6%) met the inclusion criteria and were included. There was a high prevalence of abnormal psychometry test results (NCT-A, 67.5%; NCT-B, 62.5%; DST, 70%; and OAT, 80%), and FCT-A and B were abnormal in 10 of 14 patients. Critical flicker frequency was <38 Hz in 77 patients (55%). Twelve (19.6%) of 61 patients in the HE-L group and 30 (46.8%) of 64 in the HE-NL group (P = .001) developed HE over a median follow-up of 14 months (range, 1-20 months). Readmission rate due to causes other than HE (HE-L vs HE-NL, 9:6; P = NS) and deaths (HE-L vs HE-NL, 5:11; P = .18) in 2 groups were similar. Recurrence of overt HE was significantly associated with 2 or more abnormal psychometric tests after the recovery of an episode of HE (r = 0.369, P = .02). CONCLUSIONS:
|
Authors | Barjesh Chander Sharma, Praveen Sharma, Amit Agrawal, Shiv Kumar Sarin |
Journal | Gastroenterology
(Gastroenterology)
Vol. 137
Issue 3
Pg. 885-91, 891.e1
(Sep 2009)
ISSN: 1528-0012 [Electronic] United States |
PMID | 19501587
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Gastrointestinal Agents
- Lactulose
|
Topics |
- Adult
- Female
- Gastrointestinal Agents
(therapeutic use)
- Hepatic Encephalopathy
(diagnosis, etiology, prevention & control)
- Humans
- Lactulose
(adverse effects, therapeutic use)
- Liver Cirrhosis
(complications)
- Male
- Middle Aged
- Neuropsychological Tests
- Psychometrics
- Secondary Prevention
|